Back to Search
ALVARO TALAVERA, MD
MD
Hematology & Oncology Physician
NPI: 1811985427IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
13091(PR)
Education
OTHER
Class of 2001
Research & Publications (20)
A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice.
PMID 18996426·Vaccine·2009
7-preclinical
Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
PMID 19584289·Cancer Res·2009
7-preclinical
Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified.
PMID 18247163·Med Oncol·2008
3-trial
Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14 +R) in high-risk diffuse large cell lymphoma.
PMID 17673816·Med Oncol·2007
2-rct
Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity.
PMID 17129616·J Virol Methods·2007
7-preclinical
Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study.
PMID 16620986·Mol Immunol·2007
7-preclinical
Gangliosides, Ab1 and Ab2 antibodies I. Towards a molecular dissection of an idiotype-anti-idiotype system.
PMID 16581129·Mol Immunol·2007
7-preclinical
Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
PMID 16460846·Vaccine·2006
4-observational
Colorectal cancer screening among Mexican Americans at a community clinic.
PMID 16476635·Am J Prev Med·2006
8-other
Phenotypic evolution of human craniofacial morphology after admixture: a geometric morphometrics approach.
PMID 16323202·Am J Phys Anthropol·2006
4-observational
Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638.
PMID 16085342·Vaccine·2006
7-preclinical
Biological modifiers as cytoreductive therapy before stem cell transplant in previously untreated patients with multiple myeloma.
PMID 15668273·Ann Oncol·2005
3-trial
Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy.
PMID 16019553·Leuk Lymphoma·2005
3-trial
The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
PMID 15845509·Infect Immun·2005
3-trial
Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial.
PMID 15750197·Med Oncol·2005
3-trial
Residual disease after chemotherapy in aggressive malignant lymphoma: the role of radiotherapy.
PMID 16260856·Med Oncol·2005
2-rct
Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.
PMID 15541278·J Immunol Methods·2004
7-preclinical
Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma.
PMID 15456955·Med Oncol·2004
3-trial
Maintenance therapy with interferon-alpha 2b, cyclophosphamide, and prednisone in aggressive diffuse large cell lymphoma.
PMID 15186737·Stem Cells Dev·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 65 INFANTERIA AV. KM. 8.3, HOSPITAL UPR FIRST FLOOR
CAROLINA, PR 00984 - Phone
- (787) 633-0017
Quick Facts
- NPI
- 1811985427
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile